Literature DB >> 30101996

Nutritional Risk Screening 2002 Cut-Off to Identify High-Risk Is a Good Predictor of ICU Mortality in Critically Ill Patients.

Laura Rafaela Monteiro de Almeida Maciel1, Oellen Stuani Franzosi1,2,3, Diego Silva Leite Nunes3,4, Sérgio Henrique Loss4, Audrey Machado Dos Reis5, Bibiana de Almeida Rubin1,2, Silvia Regina Rios Vieira3,4,6.   

Abstract

BACKGROUND: The Nutritional Risk Screening 2002 (NRS-2002) is a widely recommended nutrition risk indicator. Two cut-offs have been proposed for intensive care unit (ICU) patients to classify nutrition risk: ≥3-<5, at risk and ≥5, high risk. To date, no study has directly compared these cut-offs. The aim of this study is to compare the NRS-2002 ICU nutrition risk cut-offs as predictors of clinical outcomes including infections, ICU and hospital mortality, length of stay (LOS), duration of mechanical ventilation (MVd), weaning failure, tracheotomy for prolonged MVd, and chronic critical illness (CCI).
METHODS: Adult patients were screened and stratified according to NRS-2002 ICU criteria. Clinical, epidemiologic, and nutrition data were extracted from medical records. Statistical analysis for independent samples and Poisson regression were performed.
RESULTS: A total of 185 patients were screened: 1 (0.54%) no risk; 96 (51.89%) at risk, and 88 (47.56%) high risk. High-risk patients were older, had higher Simplified Acute Physiology Score 3 (62.0 ± 14.1 vs 53.0 ± 12.9, respectively; P < .001) and Sequential Organ Failure Assessment (6.9 ± 3.7 vs 5.1 ± 3.1, respectively; P < .001), and developed more infections (42 [47.8%] vs 27 [28.1%]; P = .010). No differences were found for ICU and hospital LOS, MVd days, weaning failure, tracheotomy, and CCI. ICU and hospital mortality were higher in high-risk patients. The high-risk cut-off was predictor of ICU mortality (relative risk 2.10, 95% confidence interval 1.07-4.14; P = .032).
CONCLUSION: Our data suggest that the NRS-2002 high-risk cut-off is associated with worse clinical outcomes and is a predictor for ICU mortality.
© 2018 American Society for Parenteral and Enteral Nutrition.

Entities:  

Keywords:  NRS-2002; artificial respiration; critical illness; intensive care unit; length of stay; nutrition assessment

Mesh:

Year:  2018        PMID: 30101996     DOI: 10.1002/ncp.10185

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  5 in total

1.  Practical parameters that can be used for nutritional assessment in patients hospitalized in the intensive care unit with the diagnosis of chronic obstructive pulmonary disease: Prognostic nutritional index, neutrophil-to-lymphocyte, platelet-to-lymphocyte, and lymphocyte-to-monocyte ratio.

Authors:  Ramazan Baldemir; Mustafa Özgür Cirik
Journal:  Medicine (Baltimore)       Date:  2022-06-17       Impact factor: 1.817

2.  High nutritional risk is associated with unfavorable outcomes in patients admitted to an intensive care unit.

Authors:  Julia Marchetti; Audrey Machado Dos Reis; Amanda Forte Dos Santos; Oellen Stuani Franzosi; Vivian Cristine Luft; Thais Steemburgo
Journal:  Rev Bras Ter Intensiva       Date:  2019-10-14

3.  Caloric Adequacy in the First Week of Mechanically Ventilated Patients has No Impact on Long-term Daily Life Activities.

Authors:  Angela P Dariano; Cecilia Fl Couto; Bibiana A Rubin; Marina V Viana; Gilberto Friedman
Journal:  Indian J Crit Care Med       Date:  2020-12

4.  Construction of a Prediction Model for the Mortality of Elderly Patients with Diabetic Nephropathy.

Authors:  Li Wang; Yan Lv
Journal:  J Healthc Eng       Date:  2022-09-12       Impact factor: 3.822

5.  Evaluation of the effectiveness of the Nutritional Risk Screening System 2002 (NRS-2002) in COVID-19 patients admitted to the intensive care unit.

Authors:  Babak Alikiaii; Zahra Heidari; Afshar Fazeli; Mojtaba Rahimi Varposhti; Darioush Moradi Farsani; Shirin Fattahpour; Sahar Rafiee; Mohammad Bagherniya
Journal:  Int J Clin Pract       Date:  2021-10-09       Impact factor: 3.149

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.